Delivery Order SPE2DB24D1201-SPE2DB25FJCBY
Award Date
4/1/25
Potential Completion Date
4/22/25
Potential Value
$1.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,577.72, is for the delivery of ENVARSUS XR 1 MG TABLET 100S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of February 4, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award is for the delivery of ENVARSUS XR 4 MG TABLET 100S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, the Corporate Office division of the Amerisourcebergen Corporation, a major pharmaceutical distribution company. The contract is a Delivery Order with a Firm Fixed Price of $1,615.33 and a completion date of August 2, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,041.42 firm fixed-price delivery order is for ENVARSUS XR 4 MG TABLET 100S, a specialty medication. The contract has an ultimate completion date of September 13, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award, valued at $5,995.09, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of ENVARSUS XR 4 MG TABLET 100S, a pharmaceutical product. The contract has a Firm Fixed Price pricing type and an Ultimate Completion Date of April 23, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division, valued at $1,465.68, for the supply of the pharmaceutical product ENVARSUS XR 1 MG TABLET 30S. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen provides a comprehensive range of pharmaceutical...
The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, a firm fixed price delivery order contract valued at $1,615.33 to provide ENVARSUS XR 4 MG TABLET 100S. This award is under Amerisourcebergen's existing indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary vehicle for Amerisourcebergen to deliver pharmaceuticals and medical supplies to DLA Troop...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $1,216.11 firm fixed price delivery order is for the supply of ENVARSUS XR 1 MG TABLET 100S, a pharmaceutical product. The award has a completion date of March 5, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA Troop Support...
This federal contract award, valued at $1,288.86, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ENVARSUS XR 1 MG TABLET 100S, a prescription medication. The contract has an ultimate completion date of April 14, 2025 and is a Firm Fixed Price Delivery Order. The contract was not set aside for any specific business type. Amerisourcebergen Drug Corp holds a...
This federal contract award, valued at $1,718.48, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under the company's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of ENVARSUS XR 0.75 MG tablets. The contract, valued at $1,103.64, is a Firm Fixed Price Delivery Order without any set-aside requirements. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which serves as a primary vehicle for providing a comprehensive...